呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2022 WASOG声明：结节病相关肺动脉高压的诊断和治疗

2022-02-09 世界结节病和其他肉芽肿性疾病协会 Eur Respir Rev

结节病相关肺动脉高压

2021年2月，世界结节病和其他肉芽肿性疾病协会(WASOG)发布了结节病相关肺动脉高压的诊断和治疗声明。结节病相关肺动脉高压（SAPH）是晚期结节病的重要并发症，本文主要针对结节病相关肺动脉高压的诊

中文标题：

2022 WASOG声明：结节病相关肺动脉高压的诊断和治疗

英文标题：

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension

发布机构：

世界结节病和其他肉芽肿性疾病协会

发布日期：

2022-02-09

简要介绍：

2021年2月，世界结节病和其他肉芽肿性疾病协会(WASOG)发布了结节病相关肺动脉高压的诊断和治疗声明。结节病相关肺动脉高压（SAPH）是晚期结节病的重要并发症，本文主要针对结节病相关肺动脉高压的诊断和治疗提出共识指导，主要涉及筛查、诊断和治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 WASOG声明：结节病相关肺动脉高压的诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=95c191c0023510b7, title=2022 WASOG声明：结节病相关肺动脉高压的诊断和治疗, enTitle=WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension, guiderFrom=Eur Respir Rev, authorId=0, author=, summary=2021年2月，世界结节病和其他肉芽肿性疾病协会(WASOG)发布了结节病相关肺动脉高压的诊断和治疗声明。结节病相关肺动脉高压（SAPH）是晚期结节病的重要并发症，本文主要针对结节病相关肺动脉高压的诊, cover=https://img.medsci.cn/2022211/1644589130789_1608702.jpg, journalId=0, articlesId=null, associationId=2391, associationName=世界结节病和其他肉芽肿性疾病协会, associationIntro=世界结节病和其他肉芽肿性疾病协会(WASOG,World Association of Sarcoidosis and Other Granulomatous disease), copyright=0, guiderPublishedTime=Wed Feb 09 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年2月，世界结节病和其他肉芽肿性疾病协会(WASOG)发布了结节病相关肺动脉高压的诊断和治疗声明。结节病相关肺动脉高压（SAPH）是晚期结节病的重要并发症，本文主要针对结节病相关肺动脉高压的诊断和治疗提出共识指导，主要涉及筛查、诊断和治疗。</span></p>, tagList=[TagDto(tagId=122841, tagName=结节病相关肺动脉高压)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3145, appHits=54, showAppHits=0, pcHits=300, showPcHits=3090, likes=0, shares=6, comments=3, approvalStatus=1, publishedTime=Sat Feb 12 15:15:00 CST 2022, publishedTimeString=2022-02-09, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=dajiong, createdTime=Fri Feb 11 22:24:01 CST 2022, updatedBy=6415643, updatedName=凯晨, updatedTime=Mon Jan 01 16:11:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 WASOG声明：结节病相关肺动脉高压的诊断和治疗.pdf)])
2022 WASOG声明：结节病相关肺动脉高压的诊断和治疗.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212793, encodeId=257c1212e9307, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:33:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198649, encodeId=15941198649a7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1ef5427595, createdName=大芳, createdTime=Wed Mar 02 10:53:49 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195235, encodeId=1d0f119523587, content=很不不哦<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:22:31 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
    2022-04-20 ms8000000410919385

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212793, encodeId=257c1212e9307, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:33:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198649, encodeId=15941198649a7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1ef5427595, createdName=大芳, createdTime=Wed Mar 02 10:53:49 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195235, encodeId=1d0f119523587, content=很不不哦<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:22:31 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
    2022-03-02 大芳

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212793, encodeId=257c1212e9307, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2ab5520776, createdName=ms8000000410919385, createdTime=Wed Apr 20 10:33:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198649, encodeId=15941198649a7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1ef5427595, createdName=大芳, createdTime=Wed Mar 02 10:53:49 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195235, encodeId=1d0f119523587, content=很不不哦<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:22:31 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
    2022-02-19 zenger1023

    很不不哦#学习#

    0